{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ursolic acid", "antitubercular", "eucalyptus tereticornis", "in silico docking.", "in vitro", "triterpenoid"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37946341", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "06"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/0115734064256660231027042758"], "Journal": {"ISSN": "1875-6638", "JournalIssue": {"Volume": "20", "Issue": "6", "PubDate": {"Year": "2024"}}, "Title": "Medicinal chemistry (Shariqah (United Arab Emirates))", "ISOAbbreviation": "Med Chem"}, "ArticleTitle": "Synthesis and Structural Activity Relationship Study of Ursolic Acid Derivatives as Antitubercular Agent.", "Pagination": {"StartPage": "630", "EndPage": "645", "MedlinePgn": "630-645"}, "Abstract": {"AbstractText": ["The chemical transformation of ursolic acid (UA) into novel C-3 aryl ester derivatives and <i>in vitro</i> and <i>silico</i> assessment of their antitubercular potential.", "UA is a natural pentacyclic triterpenoid with many pharmacological properties. Semisynthetic UA analogs have demonstrated enhanced anticancer, antimalarial, and antifilarial properties in our previous studies.", "The C-30 carboxylic group of previously isolated UA was protected, and various C-3 aryl ester derivatives were semi-synthesized. The agar dilution method was used to evaluate the <i>in vitro</i> antitubercular efficacy of <i>Mycobacterium tuberculosis</i> (Mtb) H<sub>37</sub>Ra. <i>In silico</i> docking studies of the active derivative were carried out against Mtb targets, catalase peroxidase (PDB: 1SJ2), dihydrofolate reductase (PDB: 4M2X), enoyl-ACP reductase (PDB: 4TRO), and cytochrome bc1 oxidase (PDB: 7E1V).", "The derivative 3-O-(2-amino,3-methyl benzoic acid)-ethyl ursolate (UA-1H) was the most active among the eight derivatives (MIC1 2.5 \u03bcg/mL) against Mtb H<sub>37</sub>Ra. Also, UA-1H demonstrated significant binding affinity in the range of 10.8-11.4 kcal/mol against the antiTb target proteins, which was far better than the positive control Isoniazid, Ethambutol, and co-crystallized ligand (HEM). Moreover, the predicted hit UA-1H showed no inhibition of Cytochrome P450 2D6 (CYP2D6), suggesting its potential for favorable metabolism in Phase I clinical studies.", "The ursolic acid derivative UA-1H possesses significant <i>in vitro</i> antitubercular potential with favorable <i>in silico</i> pharmacokinetics. Hence, further <i>in vivo</i> assessments are suggested for UA-1H for its possible development into a secure and efficient antitubercular drug."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, 226015, India."}, {"Identifier": [], "Affiliation": "Department of Chemistry, University of Lucknow, Lucknow, 226007, India."}], "LastName": "Vishwakarma", "ForeName": "Sadhna", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, 226015, India."}], "LastName": "Srivastava", "ForeName": "Santosh K", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Lucknow, Lucknow, 226007, India."}], "LastName": "Khare", "ForeName": "Naveen K", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Lucknow, Lucknow, 226007, India."}], "LastName": "Chaubey", "ForeName": "Shiwa", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biochemistry and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, 226031, India."}], "LastName": "Chaturvedi", "ForeName": "Vinita", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biochemistry and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, 226031, India."}], "LastName": "Trivedi", "ForeName": "Priyanka", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Metabolic and Structural Biology, CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, 226015, India."}], "LastName": "Khan", "ForeName": "Sana", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Metabolic and Structural Biology, CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, 226015, India."}], "LastName": "Khan", "ForeName": "Feroz", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Med Chem", "NlmUniqueID": "101240303", "ISSNLinking": "1573-4064"}, "ChemicalList": [{"RegistryNumber": "P3M2575F3F", "NameOfSubstance": "Ursolic Acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Antitubercular Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Ursolic Acid"}, {"QualifierName": ["pharmacology", "chemical synthesis", "chemistry"], "DescriptorName": "Triterpenes"}, {"QualifierName": ["pharmacology", "chemical synthesis", "chemistry"], "DescriptorName": "Antitubercular Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mycobacterium tuberculosis"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sparg S.G.; Light M.E.; van Staden J.; Biological activities and distribution of plant saponins. J Ethnopharmacol 2004,94(2-3),219-243", "ArticleIdList": ["10.1016/j.jep.2004.05.016", "15325725"]}, {"Citation": "Liu J.; Oleanolic acid and ursolic acid: Research perspectives. J Ethnopharmacol 2005,100(1-2),92-94", "ArticleIdList": ["10.1016/j.jep.2005.05.024", "15994040"]}, {"Citation": "Kalani K.; Yadav D.K.; Khan F.; Srivastava S.K.; Suri N.; Pharmacophore, QSAR, and ADME based semisynthesis and In vitro evaluation of ursolic acid analogs for anticancer activity. J Mol Model 2012,18(7),3389-3413", "ArticleIdList": ["10.1007/s00894-011-1327-6", "22271093"]}, {"Citation": "Novotn\u00fd L.; Vach\u00e1lkov\u00e1 A.; Biggs D.; Ursolic acid: An anti-tumorigenic and chemopreventive activity. Minireview. Neoplasma 2001,48(4),241-246", "ArticleIdList": ["11712672"]}, {"Citation": "Zhou D.; Bao Q.; Fu S.; Anticancer activity of ursolic acid on retinoblastoma cells determined by bioinformatics analysis and validation. Ann Transl Med 2021,9(20),1548", "ArticleIdList": ["10.21037/atm-21-4617", "34790754"]}, {"Citation": "Haridas V.; Arntzen C.J.; Gutterman J.U.; Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-\u03baB by inhibiting both its nuclear localization and ability to bind DNA. Proc Natl Acad Sci USA 2001,98(20),11557-11562", "ArticleIdList": ["10.1073/pnas.191363498", "11572998"]}, {"Citation": "Jung H.J.; Nam J.H.; Choi J.; Lee K.T.; Park H.J.; 19\u03b1-hydroxyursane-type triterpenoids: Antinociceptive anti-inflammatory principles of the roots of Rosa rugosa. Biol Pharm Bull 2005,28(1),101-104", "ArticleIdList": ["10.1248/bpb.28.101", "15635171"]}, {"Citation": "Nataraj A.; Raghavendra G.C.; Rajesh R.; Vishwanath B.; Group IIA secretory PLA2 inhibition by ursolic acid: A potent anti-inflammatory molecule. Curr Top Med Chem 2007,7(8),801-809", "ArticleIdList": ["10.2174/156802607780487696", "17456043"]}, {"Citation": "Ikeda Y.; Murakami A.; Ohigashi H.; Ursolic acid: An anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res 2008,52(1),26-42", "ArticleIdList": ["10.1002/mnfr.200700389", "18203131"]}, {"Citation": "Ikeda T.; Yokomizo K.; Okawa M.; Tsuchihashi R.; Kinjo J.; Nohara T.; Uyeda M.; Anti-herpes virus type 1 activity of oleanane-type triterpenoids. Biol Pharm Bull 2005,28(9),1779-1781", "ArticleIdList": ["10.1248/bpb.28.1779", "16141560"]}, {"Citation": "Kalani K.; Kushwaha V.; Sharma P.; Verma R.; Srivastava M.; Khan F.; Murthy P.K.; Srivastava S.K.; In vitro, in silico and In vivo studies of ursolic acid as an anti-filarial agent. PLoS One 2014,9(11),e111244", "ArticleIdList": ["10.1371/journal.pone.0111244", "25375886"]}, {"Citation": "Ma C.M.; Cai S.Q.; Cui J.R.; Wang R.Q.; Tu P.F.; Hattori M.; Daneshtalab M.; Daneshtalab M.; The cytotoxic activity of ursolic acid derivatives. Eur J Med Chem 2005,40(6),582-589", "ArticleIdList": ["10.1016/j.ejmech.2005.01.001", "15922841"]}, {"Citation": "Feng J.H.; Chen W.; Zhao Y.; Ju X.L.; Anti-tumor activity of oleanolic, ursolic and glycyrrhetinic acid. Open Nat Prod J 2009,2(1),48-52", "ArticleIdList": ["10.2174/1874848100902010048"]}, {"Citation": "Maurya A.; Khan F.; Bawankule D.U.; Yadav D.K.; Srivastava S.K.; QSAR, docking and in vivo studies for immunomodulatory activity of isolated triterpenoids from Eucalyptus tereticornis and Gentiana kurroo. Eur J Pharm Sci 2012,47(1),152-161", "ArticleIdList": ["10.1016/j.ejps.2012.05.009", "22659375"]}, {"Citation": "J\u00e4ger S.; Trojan H.; Kopp T.; Laszczyk M.; Scheffler A.; Pentacyclic triterpene distribution in various plants - rich sources for a new group of multi-potent plant extracts. Molecules 2009,14(6),2016-2031", "ArticleIdList": ["10.3390/molecules14062016", "19513002"]}, {"Citation": "Hussain H.; Green I.R.; Ali I.; Khan I.A.; Ali Z.; Al-Sadi A.M.; Ahmed I.; 2012-2016. Ursolic acid derivatives for pharmaceutical use: A patent review. Expert Opin Ther Pat 2017,27(9),1061-1072", "ArticleIdList": ["10.1080/13543776.2017.1344219", "28637397"]}, {"Citation": "Mancha-Ramirez A.M.; Slaga T.J.; Ursolic acid and chronic disease: An overview of UA\u2019s effects on prevention and treatment of obesity and cancer. Adv Exp Med Biol 2016,75-96", "ArticleIdList": ["10.1007/978-3-319-41334-1_4"]}, {"Citation": "Global tuberculosis report. World Health Organization Available from: http s://www.who.int/.../tb-reports/global-tuberculosis-report-20222022"}, {"Citation": "Gupta S.; Dwivedi G.R.; Darokar M.P.; Srivastava S.K.; Antimycobacterial activity of fractions and isolated compounds from Vetiveria zizanioides. Med Chem Res 2012,21(7),1283-1289", "ArticleIdList": ["10.1007/s00044-011-9639-8"]}, {"Citation": "Quan D.; Nagalingam G.; Payne R.; Triccas J.A.; New tuberculosis drug leads from naturally occurring compounds. Int J Infect Dis 2017,56,212-220", "ArticleIdList": ["10.1016/j.ijid.2016.12.024", "28062229"]}, {"Citation": "Zerin T.; Lee M.; Jang W.S.; Nam K.W.; Song H.Y.; Anti-inflammatory potential of ursolic acid in Mycobacterium tuberculosis-sensitized and Concanavalin A-stimulated cells. Mol Med Rep 2016,13(3),2736-2744", "ArticleIdList": ["10.3892/mmr.2016.4840", "26847129"]}, {"Citation": "do Nascimento P.; Lemos T.; Bizerra A.; Arriaga \u00c2.; Ferreira D.; Santiago G.; Braz-Filho R.; Costa J.; Antibacterial and antioxidant activities of ursolic acid and derivatives. Molecules 2014,19(1),1317-1327", "ArticleIdList": ["10.3390/molecules19011317", "24451251"]}, {"Citation": "Nguta J.M.; Appiah-Opong R.; Nyarko A.K.; Yeboah-Manu D.; Addo P.G.A.; Current perspectives in drug discovery against tuberculosis from natural products. Int J Mycobacteriol 2015,4(3),165-183", "ArticleIdList": ["10.1016/j.ijmyco.2015.05.004", "27649863"]}, {"Citation": "Salomon C.E.; Schmidt L.E.; Natural products as leads for tuberculosis drug development. Curr Top Med Chem 2012,12(7),735-765", "ArticleIdList": ["10.2174/156802612799984526", "22283816"]}, {"Citation": "Maurya A.; Srivastava S.K.; Determination of ursolic acid and ursolic acid lactone in the leaves of Eucalyptus tereticornis by HPLC. J Braz Chem Soc 2012,23(3),468-472", "ArticleIdList": ["10.1590/S0103-50532012000300013"]}, {"Citation": "Seebacher W.; Simic N.; Weis R.; Saf R.; Kunert O.; Complete assignments of1H and13C NMR resonances of oleanolic acid, 18?-oleanolic acid, ursolic acid and their 11-oxo derivatives. Magn Reson Chem 2003,41(8),636-638", "ArticleIdList": ["10.1002/mrc.1214"]}, {"Citation": "Kenneth McClatchy J.; Susceptibility testing of mycobacteria. Lab Med 1978,9(3),47-52", "ArticleIdList": ["10.1093/labmed/9.3.47"]}, {"Citation": "Bhukya B.; Alam S.; Chaturvedi V.; Trivedi P.; Kumar S.; Khan F.; Negi A.S.; Srivastava S.K.; Brevifoliol and its analogs: A new class of anti-tubercular agents. Curr Top Med Chem 2021,21(9),767-776", "ArticleIdList": ["10.2174/1568026620666200528155236", "32484109"]}, {"Citation": "Tembe N.; Machaba K.E.; Ndagi U.; Kumalo H.M.; Mhlongo N.N.; Ursolic acid as a potential inhibitor of Mycobacterium tuberculosis cytochrome bc1 oxidase-a molecular modelling perspective. J Mol Model 2022,28(2),35", "ArticleIdList": ["10.1007/s00894-021-04993-w", "35022913"]}, {"Citation": "Kapkoti D.S.; Singh S.; Alam S.; Khan F.; Luqman S.; Bhakuni R.S.; In vitro antiproliferative activity of glabridin derivatives and their in silico target identification. Nat Prod Res 2020,34(12),1735-1742", "ArticleIdList": ["10.1080/14786419.2018.1530228", "30580626"]}, {"Citation": "Bhukya B.; Shukla A.; Chaturvedi V.; Trivedi P.; Kumar S.; Khan F.; Negi A.S.; Srivastava S.K.; Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents. Bioorg Chem 2020,99,103784", "ArticleIdList": ["10.1016/j.bioorg.2020.103784", "32361184"]}, {"Citation": "Alam S.; Khan F.; 3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7. Sci Rep 2017,7(1),6019", "ArticleIdList": ["10.1038/s41598-017-06131-0", "28729623"]}, {"Citation": "Tyagi R.; Verma S.; Mishra S.; Srivastava M.; Alam S.; Khan F.; Srivastava S.K.; In vitro and In silico studies of glycyrrhetinic acid derivatives as anti-filarial agents. Curr Top Med Chem 2019,19(14),1191-1200", "ArticleIdList": ["10.2174/1568026619666190618141450", "31210109"]}, {"Citation": "Alam S.; Khan F.; QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity. J Biomol Struct Dyn 2018,36(9),2373-2390", "ArticleIdList": ["10.1080/07391102.2017.1355846", "28705120"]}, {"Citation": "Dassault Syst\u00e8mes B.I.O.V.I.A.; Discovery Studio Modeling Environment, Release 2017 2016"}, {"Citation": "Almeida Da Silva P.E.; Palomino J.C.; Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: Classical and new drugs. J Antimicrob Chemother 2011,66(7),1417-1430", "ArticleIdList": ["10.1093/jac/dkr173", "21558086"]}, {"Citation": "Schroeder E.; de Souza O.; Santos D.; Blanchard J.; Basso L.; Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Curr Pharm Biotechnol 2002,3(3),197-225", "ArticleIdList": ["10.2174/1389201023378328", "12164478"]}, {"Citation": "Jyoti M.A.; Zerin T.; Kim T.H.; Hwang T.S.; Jang W.S.; Nam K.W.; Song H.Y.; In vitro effect of ursolic acid on the inhibition of Mycobacterium tuberculosis and its cell wall mycolic acid. Pulm Pharmacol Ther 2015,33,17-24", "ArticleIdList": ["10.1016/j.pupt.2015.05.005", "26021818"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "10"}, {"Year": "2023", "Month": "9", "Day": "30"}, {"Year": "2023", "Month": "10", "Day": "5"}, {"Year": "2024", "Month": "8", "Day": "6", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "11", "Day": "10", "Hour": "6", "Minute": "45"}, {"Year": "2023", "Month": "11", "Day": "10", "Hour": "0", "Minute": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37946341", "10.2174/0115734064256660231027042758", "MC-EPUB-135971"]}}], "PubmedBookArticle": []}